- Home
- ATOS vs NNY Comparison
ATOS vs NNY Comparison
Compare ATOS & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- NNY
- Stock Information
- Founded
- ATOS 2009
- NNY 1987
- Country
- ATOS United States
- NNY United States
- Employees
- ATOS N/A
- NNY N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- ATOS Health Care
- NNY Finance
- Exchange
- ATOS Nasdaq
- NNY Nasdaq
- Market Cap
- ATOS 174.8M
- NNY 163.0M
- IPO Year
- ATOS 2012
- NNY N/A
- Fundamental
- Price
- ATOS $1.19
- NNY $8.31
- Analyst Decision
- ATOS Strong Buy
- NNY
- Analyst Count
- ATOS 3
- NNY 0
- Target Price
- ATOS $6.75
- NNY N/A
- AVG Volume (30 Days)
- ATOS 738.2K
- NNY 50.9K
- Earning Date
- ATOS 11-12-2024
- NNY 01-01-0001
- Dividend Yield
- ATOS N/A
- NNY 4.04%
- EPS Growth
- ATOS N/A
- NNY N/A
- EPS
- ATOS N/A
- NNY N/A
- Revenue
- ATOS N/A
- NNY N/A
- Revenue This Year
- ATOS N/A
- NNY N/A
- Revenue Next Year
- ATOS N/A
- NNY N/A
- P/E Ratio
- ATOS N/A
- NNY N/A
- Revenue Growth
- ATOS N/A
- NNY N/A
- 52 Week Low
- ATOS $0.70
- NNY $7.58
- 52 Week High
- ATOS $2.31
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- ATOS 31.91
- NNY 38.48
- Support Level
- ATOS $1.26
- NNY $8.21
- Resistance Level
- ATOS $1.66
- NNY $8.38
- Average True Range (ATR)
- ATOS 0.09
- NNY 0.08
- MACD
- ATOS -0.03
- NNY -0.00
- Stochastic Oscillator
- ATOS 4.08
- NNY 38.46
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.